Phase II evaluation of didemnin B in hormonally refractory metastatic prostate cancer - A southwest oncology group study

Stephen K. Williamson, Michael K. Wolf, Mario A. Eisenberger, Mark O'Rourke, William Brannon, E. David Crawford

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Phase II evaluation of didemnin B in hormonally refractory metastatic prostate cancer - A southwest oncology group study'. Together they form a unique fingerprint.

Medicine & Life Sciences